Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease-Reference-Cited by-同舟云学术

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease

Published:2018-07-25 Issue:9 Volume:70 Page:1508-1518
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Lovell Daniel J.¹,Johnson Anne L.¹,Huang Bin¹,Gottlieb Beth S.²,Morris Paula W.³,Kimura Yukiko⁴,Onel Karen⁵,Li Suzanne C.⁴^ORCID,Grom Alexei A.¹,Taylor Janalee¹,Brunner Hermine I.¹,Huggins Jennifer L.¹,Nocton James J.⁶,Haines Kathleen A.⁴,Edelheit Barbara S.⁷,Shishov Michael⁸,Jung Lawrence K.⁹,Williams Calvin B.⁶,Tesher Melissa S.¹⁰,Costanzo Denise M.²,Zemel Lawrence S.⁷,Dare Jason A.³,Passo Murray H.¹¹,Ede Kaleo C.⁸,Olson Judyann C.⁶,Cassidy Elaine A.¹²,Griffin Thomas A.¹,Wagner-Weiner Linda¹⁰,Weiss Jennifer E.⁴,Vogler Larry B.¹³,Rouster-Stevens Kelly A.¹³,Beukelman Timothy¹⁴,Cron Randy Q.¹⁴,Kietz Daniel¹²,Schikler Kenneth¹⁵,Schmidt Kara M.¹⁵,Mehta Jay¹⁶,Wahezi Dawn M.¹⁶,Ting Tracy V.¹,Verbsky James W.⁶,Eberhard B. Anne⁴,Spalding Steven¹⁷,Chen Chen¹,Giannini Edward H.¹

Affiliation:

1. Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

2. The Steven and Alexandra Cohen Children's Medical Center of New York; New Hyde Park New York

3. University of Arkansas for Medical Science; Little Rock

4. Hackensack University Medical Center; Joseph M. Sanzari Children's Hospital; Hackensack New Jersey

5. Hospital for Special Surgery, Weill Cornell Medicine; New York New York

6. Medical College of Wisconsin; Milwaukee

7. Connecticut Children's Medical Center; Hartford

8. Phoenix Children's Hospital; Phoenix Arizona

9. Children's National Medical Center; Washington DC

10. University of Chicago; Comer Children's Hospital; Chicago Illinois

11. Medical University of South Carolina; Charleston

12. Children's Hospital of Pittsburgh; Pittsburgh Pennsylvania

13. Emory University School of Medicine; Atlanta Georgia

14. University of Alabama at Birmingham

15. University of Louisville; Louisville Kentucky

16. Children's Hospital at Montefiore; Bronx New York

17. Cleveland Clinic Foundations; Cleveland Ohio

Funder

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40509/fullpdf

Reference46 articles.

1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty;J Rheumatol,2004

2. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis;Wallace;Arthritis Care Res (Hoboken),2011

3. Patterns of clinical remission in select categories of juvenile idiopathic arthritis;Wallace;Arthritis Rheum,2005

4. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors;Wallace;J Rheumatol,2014

5. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial;Ruperto;Lancet,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?;Archives of Rheumatology;2023-08-23

2. What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?;The Journal of Rheumatology;2023-08-01

3. When to stop medication in juvenile idiopathic arthritis;Current Opinion in Rheumatology;2023-05-03

4. Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes;Expert Opinion on Biological Therapy;2023-03-01

5. Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials;Arthritis Care & Research;2023-01-18